基于5.2万例常规临床数据刻画癌症恶病质的发生与进展
Characterizing the onset and progression of cancer cachexia using routine clinical data
一项纳入52,236例癌症患者的分析显示,恶病质性体重下降与更低生存率相关,且多出现在疾病进展时期。常规实验室指标呈现一致的血清学特征,TP53等特定肿瘤基因型与恶病质风险呈正相关。研究者据此训练统计模型,用于预测患者即将发生的恶病质风险。
基于5.2万余例患者常规临床数据,勾勒恶病质发生与进展的时间线,为早期识别提供可迁移的数据路径。
Nature Medicine, Published online: 13 October 2026; doi:10.1038/s41591-026-04720-z
In 52,236 patients with cancer, cachectic weight loss episodes were linked to lower survival rates, occurred at times of disease progression, and carried a consistent serological signature across routine laboratory markers. Specific tumor genotypes, including TP53 mutations, were also positively associated with cachexia risk. Statistical models were trained to predict a patient’s impending risk of cachexia.
来源:Nature Medicine · nature.com